Naber D - Search Results

1

Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.

Lambert M, Haro JM, Novick D, Edgell ET, Kennedy L, Ratcliffe M, Naber D. Lambert M, et al. Among authors: naber d. Acta Psychiatr Scand. 2005 Mar;111(3):232-43. doi: 10.1111/j.1600-0447.2004.00451.x. Acta Psychiatr Scand. 2005. PMID: 15701108

2

[Atypical antipsychotics in therapy refractory schizophrenia].

Schäfer I, Lambert M, Naber D. Schäfer I, et al. Among authors: naber d. Nervenarzt. 2004 Jan;75(1):79-91. doi: 10.1007/s00115-003-1662-7. Nervenarzt. 2004. PMID: 14997870 German.

3

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.

Naber D, Riedel M, Klimke A, Vorbach EU, Lambert M, Kühn KU, Bender S, Bandelow B, Lemmer W, Moritz S, Dittmann RW. Naber D, et al. Acta Psychiatr Scand. 2005 Feb;111(2):106-15. doi: 10.1111/j.1600-0447.2004.00486.x. Acta Psychiatr Scand. 2005. PMID: 15667429 Clinical Trial.

4

Subjective well-being under the neuroleptic treatment and its relevance for compliance.

Naber D, Karow A, Lambert M. Naber D, et al. Acta Psychiatr Scand Suppl. 2005;(427):29-34. doi: 10.1111/j.1600-0447.2005.00542.x. Acta Psychiatr Scand Suppl. 2005. PMID: 15943008 Review.

5

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.

Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, Naber D, McGorry PD, Schimmelmann BG. Lambert M, et al. Among authors: naber d. Acta Psychiatr Scand. 2005 Aug;112(2):141-8. doi: 10.1111/j.1600-0447.2005.00554.x. Acta Psychiatr Scand. 2005. PMID: 15992396

6

Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride.

Lambert M, Naber D, Eich FX, Schacht M, Linden M, Schimmelmann BG. Lambert M, et al. Among authors: naber d. Acta Psychiatr Scand. 2007 Feb;115(2):106-13. doi: 10.1111/j.1600-0447.2006.00862.x. Acta Psychiatr Scand. 2007. PMID: 17244174 Clinical Trial.

7

Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.

Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, Huber CG, Suarez D, Haro JM, Novick D, Dittmann RW, Schimmelmann BG. Lambert M, et al. Among authors: naber d. Acta Psychiatr Scand. 2008 Sep;118(3):220-9. doi: 10.1111/j.1600-0447.2008.01213.x. Acta Psychiatr Scand. 2008. PMID: 18699954

8

Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.

Krausz M, Moritz S, Lambert M, Naber D. Krausz M, et al. Among authors: naber d. Int Clin Psychopharmacol. 2000 Mar;15(2):77-81. doi: 10.1097/00004850-200015020-00003. Int Clin Psychopharmacol. 2000. PMID: 10759338

9

Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.

Lambert M, Schimmelmann BG, Karow A, Naber D. Lambert M, et al. Among authors: naber d. Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S181-90. doi: 10.1055/s-2003-45128. Pharmacopsychiatry. 2003. PMID: 14677077 Review.

10

Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study.

Lambert M, Conus P, Schimmelmann BG, Eide P, Ward J, Yuen H, Schacht M, Edwards J, Naber D, McGorry PD. Lambert M, et al. Among authors: naber d. Pharmacopsychiatry. 2005 Sep;38(5):206-13. doi: 10.1055/s-2005-873155. Pharmacopsychiatry. 2005. PMID: 16189747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters